Tesamorelin 5mg

CAS Number: 218949-48-5 Disclaimer: For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Overview Tesamorelin is a synthetic analog of growth hormone releasing hormone (GHRH) engineered for enhanced stability and prolonged biological activity in research settings. It is widely studied for its interaction with growth hormone signaling pathways, IGF-1 modulation, and hypothalamic-pituitary axis regulation. Experimental models commonly investigate Tesamorelin in studies involving metabolic signaling, endocrine communication, lipid metabolism, cellular recovery pathways, and body-composition-associated research. Its modified structure allows increased resistance to enzymatic degradation compared to endogenous GHRH peptides. Mechanism of Action Tesamorelin functions as a GHRH receptor agonist studied for its ability to stimulate endogenous growth hormone signaling through pituitary-associated pathways. Research suggests this interaction may influence IGF-1 signaling, metabolic regulation, lipid utilization, and endocrine pathway activity. Laboratory investigations frequently examine Tesamorelin in models involving pulsatile growth hormone release, metabolic adaptation, cellular recovery signaling, and hypothalamic-pituitary communication. Specifications Form: Lyophilized powder Quantity: 5MG per vial Grade: Research Use Only Storage: Store in a cool, dry environment away from direct light Purity specification: ≥99% (HPLC-tested). CAS number: 218949-48-5. Category: Hormonal & Growth.

For research use only. Not for human consumption.